Ginsenoside Rb1 as a neuroprotective agent: a review

Touqeer Ahmed, Syed Hammad Raza, Afifa Maryam, William N. Setzer, Nady Braidy, Seyed Fazel Nabavi, Marcos Roberto De Oliveira, Seyed Mohammad Nabavi*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

73 Citations (Scopus)


Ginsenosides represent the major bioactive components of ginseng. These triterpenoid saponins have been shown to exert numerous beneficial effects on the human body. Recent evidences suggest that ginsenosides may be useful for the management and treatment of several diseases of the central nervous system (CNS). In particular, numerous in vitro and in vivo models have shown that ginsenosides can modulate numerous pharmacological effects on the brain, including attenuation of excitotoxicity, oxidative stress and neuroinflammation, maintenance of neurotransmitter balance, anti-apoptotic effects, and mitochondrial stabilization effects. Regulations of these pathophysiological mechanisms have been shown to improve cognitive function and protect the brain against several neurodegenerative diseases. This review will critically address the pharmacological effects and mechanisms of action of ginsenosides in the CNS, and particularly those associated with therapeutic efficacies in Parkinson's disease, Alzheimer's disease, Huntington's disease, and traumatic brain injury, and ischemia.

Original languageEnglish
Pages (from-to)30-43
Number of pages14
JournalBrain Research Bulletin
Publication statusPublished - 1 Jul 2016
Externally publishedYes


  • Alzheimer’s disease
  • Ginseng
  • Ginsenosides
  • Neurodegeneration
  • Parkinson’s disease


Dive into the research topics of 'Ginsenoside Rb1 as a neuroprotective agent: a review'. Together they form a unique fingerprint.

Cite this